Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Flanagan

Showing results (601-610 of 644) with videos related to

Pageof 65
Sort By:
Neurology|December 16, 2022
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter StudySara Carta, Álvaro Cobo Calvo, Thaís Armangué, et al.
Multiple Sclerosis and Related Disorders|January 17, 2022
OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MSJohn J Chen, Elias S Sotirchos, Amanda D Henderson, et al.
American Journal of Hematology|January 3, 2022
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester diseaseJithma P Abeykoon, Terra L Lasho, Surendra Dasari, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 15, 2025
Treatment response in children with relapsing MOG-antibody associated diseaseEva-Maria Wendel, John J Chen, Annikki Bertolini, et al.
Annals of Clinical and Translational Neurology|February 11, 2025
Assessment of concurrent neoplasms and a paraneoplastic association in MOGADYoung Nam Kwon, Nanthaya Tisavipat, Yong Guo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 4, 2024
Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated diseaseAkash Virupakshaiah, Vinicius A Schoeps, Jonathan Race, et al.
Annals of Neurology|April 9, 2024
Diagnostic Utility of MOG Antibody Testing in Cerebrospinal FluidVyanka Redenbaugh, James P Fryer, Laura Cacciaguerra, et al.
Blood Cancer Journal|June 20, 2024
Clinical features and outcomes in primary nervous system histiocytic neoplasmsNabeela Nathoo, Joon H Uhm, Alyx B Porter, et al.
Nature|April 24, 2024
Emx2 underlies the development and evolution of marsupial gliding membranesJorge A Moreno, Olga Dudchenko, Charles Y Feigin, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
Pageof 65

Showing results (601-610 of 644) with videos related to

Sort By:
Pageof 65
Neurology|December 16, 2022
Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF: A Retrospective Multicenter StudySara Carta, Álvaro Cobo Calvo, Thaís Armangué, et al.
Multiple Sclerosis and Related Disorders|January 17, 2022
OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MSJohn J Chen, Elias S Sotirchos, Amanda D Henderson, et al.
American Journal of Hematology|January 3, 2022
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester diseaseJithma P Abeykoon, Terra L Lasho, Surendra Dasari, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 15, 2025
Treatment response in children with relapsing MOG-antibody associated diseaseEva-Maria Wendel, John J Chen, Annikki Bertolini, et al.
Annals of Clinical and Translational Neurology|February 11, 2025
Assessment of concurrent neoplasms and a paraneoplastic association in MOGADYoung Nam Kwon, Nanthaya Tisavipat, Yong Guo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 4, 2024
Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated diseaseAkash Virupakshaiah, Vinicius A Schoeps, Jonathan Race, et al.
Annals of Neurology|April 9, 2024
Diagnostic Utility of MOG Antibody Testing in Cerebrospinal FluidVyanka Redenbaugh, James P Fryer, Laura Cacciaguerra, et al.
Blood Cancer Journal|June 20, 2024
Clinical features and outcomes in primary nervous system histiocytic neoplasmsNabeela Nathoo, Joon H Uhm, Alyx B Porter, et al.
Nature|April 24, 2024
Emx2 underlies the development and evolution of marsupial gliding membranesJorge A Moreno, Olga Dudchenko, Charles Y Feigin, et al.
Annals of Neurology|July 3, 2023
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?Bo Chen, Enrique Gomez-Figueroa, Vyanka Redenbaugh, et al.
Pageof 65